MedPath

Study of a Strategy to Prevent Oversedation in Intensive Care Patients Under Mechanical Ventilation

Not Applicable
Completed
Conditions
ICU Patients Requiring Invasive Mechanical Ventilation
Registration Number
NCT01617265
Lead Sponsor
French Society for Intensive Care
Brief Summary

The purpose of the present study is to determine whether administration of sedation according to a strategy including a bundle of measures to prevent oversedation is associated with a reduction in mortality of intensive care unit patients requiring mechanical ventilation, compared to administration of sedation according to usual practices.

Detailed Description

In intensive care unit (ICU) patients receiving mechanical ventilation (MV), potent hypnotics and morphinics are frequently administered to increase synchrony with the ventilator, control agitation and decrease discomfort and pain due to the tracheal tube, bed ridding, painful condition and diagnostic or therapeutic procedures.

However, administration sedatives or morphinics is often excessive and may result in deep and prolonged alteration of consciousness, delayed weaning from MV and prolonged MV. and exposes the patient to a higher risk of ventilator-associated pneumonia, ICU delirium and neuromuscular weakness at awakening.

The present randomized multicenter study will compare the day-90 mortality of a group of patients receiving conventional sedation to the mortality of a group of patients receiving sedation administered according to an algorithm aimed to prevent oversedation to the mortality. The algorithm is built on a graduate therapeutic response to increasingly intense symptoms of discomfort, pain, ventilator dyssynchrony and agitation, and includes the use of analgesics, non hypnotic benzodiazepines, neuroleptics, repeated intravenous (IV) boluses of hypnotics and short duration (6 hours) IV hypnotic infusions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1180
Inclusion Criteria
  • Age 18 and older
  • Admission to ICU with expected mechanical ventilation duration > 48 hrs
  • Mechanical ventilation in ICU for less than 12 hours
  • Information provided to the patient or proxy
Exclusion Criteria
  • ICU Admission after cardiac arrest
  • Acute or chronic neuromuscular disease
  • Tracheotomy on ICU admission
  • Acute cerebral injury with intracranial hypertension requiring continuous IV sedation with or without neuromuscular blockade
  • Status epilepticus
  • Treatment withdrawal decision
  • Pregnancy, breast feeding
  • Concurrent participation in another interventional study requiring a change in usual practice of sedation or mechanical ventilation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Day-90 mortalityMortality at Day 90 after randomization
Secondary Outcome Measures
NameTimeMethod
1-yr mortalityat 1 yr
Mortality at Day 28at day 28
Hospital mortalityat hospital discharge, up to day 90
Number of patients requiring tracheotomyDuring ICU stay, up to day 28
First sitting in chairDuring ICU stay, up to day 28
Mechanical ventilation durationFrom onset of mechanical ventilation to day 28
Days alive with no mechanical ventilationFrom ICU admission up to day 28
Occurence of ventilator-associated pneumoniaDuring mechanical ventilation duration, up to day 28
Use of non-invasive ventilation after extubationFrom extubation to ICU discharge up to day 28
Duration of ICU stayFrom ICU admission to ICU discharge or death in ICU, up to day 90
ICU confusionFrom Day 1 to 7, and at day 14, 21 and 28

Number of patients alive, awaken, and free of ICU-delirium assessed on the CAM-ICU

Proximal muscle weaknessfrom day 1 to 7, and at day 14, 21 and 28

Number of patients alive, awaken, cooperative and free of proximal muscle weakness

Functional, cognitive and psychological statusAt day 90 and 1 year

Functional status (measured on the Barthel scale), depression (measured on the Hospital Anxiety \& Depression Scale), Posttraumatic stress disorder (measured on the Impact of Event Scale), Quality of Life (measured on the SF-36) and patient living location

Time to weaning onsetTime from mechancial ventilation initiation to first spontaneous breathing trial, up to day 28

Trial Locations

Locations (43)

Hôpital Saint-Esprit

🇫🇷

Agen, France

CHU d'Angers

🇫🇷

Angers, France

Hopital Privé d'Antony

🇫🇷

Antony, France

CH d'Argenteuil

🇫🇷

Argenteuil, France

CH Germon et Gauthier

🇫🇷

Beuvry, France

Hopital Avicenne

🇫🇷

Bobigny, France

Hopital St-Andre

🇫🇷

Bordeaux, France

Hopital Ambroise Pare

🇫🇷

Boulogne Billancourt, France

CHRU de la Cavale Blanche

🇫🇷

Brest, France

Hopital Antoine Beclere

🇫🇷

Clamart, France

Scroll for more (33 remaining)
Hôpital Saint-Esprit
🇫🇷Agen, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.